LFST - CIK 0001845257
The table below shows LifeStance Health Group, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|---|
| Operating cash flow | $146.15M | $107.26M | -$16.88M | $52.79M | $9.42M | $17.05M |
| Capital expenditure | $36.13M | $21.57M | $40.52M | $79.25M | $94.49M | $14.31M |
| Investing cash flow | -$36.13M | -$21.57M | -$60.34M | -$139.46M | -$194.08M | -$73.38M |
| Dividends paid | - | - | - | - | - |
LifeStance Health Group, Inc. reported operating cash flow of $146.15M for fiscal year 2025. That is up 36.3% from $107.26M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from $17.05M (FY 2019) to $146.15M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$15.96M | -$9.95M | $47.43M | $47.26M | $313.86M | $48.46M |